Hemas Holdings Ltd. · CSELK:HHL.N0000
Hemas — Q4 FY2024/25 Earnings Presentation
30 slides from Hemas's earnings presentation, 2025
Slide 1: Hemas Holdings PLC Investor Presentation Q4 FY24/25
Hemas Holdings PLC Investor Presentation- Q4 FY24/25
Slide 2: Who We Are
Who We Are Established in 1948, with a purpose of empowering families to live a better tomorrow, Hemas Holdings is one of Sri Lanka’s leading conglomerates listed in the Colombo Stock Exchange with focused interest in Consumer Brands and Healthcare. USD 1948 2003 2007 2013 2018 2022 76 241Mn Years i
Slide 3: Implications of Key Macro Economic Parameters on Hemas
Implications of Key Macro Economic Parameters on Hemas Interest Rates Stable Exchange Rates Global Commodity prices “Prices of key commodities saw an “Continued decline in AWPLR was “The Rupee remained mostly increase, especially Palm Oil, and witnessed during the year easing stable, positively impa
Slide 4: Corporate Governance
Corporate Governance BOM Group CEO Nomination & Governance BOM (Board of Management) Consists of the senior leadership team of 11 members - Heads of our 6 businesses and 5 leaders from Corporate Committee Office. BOM is responsible for formulation and implementation of Group strategic plan and ensur
Slide 5: Group Performance (Annual)
Group Performance (Annual) Revenue (LKR Mn) 5 Year CAGR 14.5% 113,940 121,614 117,970 78,831 64,501 2021 2022 2023 2024 2025 EBIT (LKR Mn) and EBIT Margin Earnings (LKR Mn) and Earnings Margin 5 Year CAGR 31.2% 5 Year CAGR 45.4% 9,000 8.0% 8,000 7.0% 6.8% 13,707 7,000 6.0% 11,921 6,000 5.4% 10,963 5
Slide 6: Long Range Plan: Key Focus Areas
Long Range Plan : Key Focus Areas ❖ Invest in complementary Hair and ❖ Shift focus to growing the ❖ Continue to strengthen a lean Beauty care, focus on local Morison brand in cardiac, diabetes, business model. consumer needs, and drive and complementary medication, household penetration in while enh
Slide 7: Awards and Recognitions
Awards and Recognitions Hemas Manufacturing (Pvt) Atlas was recognized as the In recognition of its Ltd. has been awarded the ‘School Supply Brand of the operational excellence, Hemas ‘Authorized Economic Year’ at the prestigious SLIM- Hospitals was named as the Operator (AEO) Tier 1 Kantar People’s
Slide 8: New Product Launches During the Quarter
New Product Launches During the Quarter Personal Care - SL Consumer Brands - Pharmaceuticals International Manufacturing CliniMor RivoMor ‘Clogard’ salt ‘Goya’ vibrant Clogard Proclean ‘Vibe’ range of based fruity fragrance BisoMor Limited Edition fragrances toothpaste toothbrush (Re-launch)
Slide 9: Financial Snapshot
Financial Snapshot 12M contribution to the Group EBIT by Sector 5,500,000 2% 4,500,000 39% 59% 3,500,000 50% 48% 11% Revenue Rs, ‘000 2,500,000 1,500,000 EBIT 2% 500,000 -500,000 Q4 FY 23/24 Q1 FY 24/25 Q2 FY 24/25 Q3 FY 24/25 Q4 FY 24/25 Consumer Healthcare Mobility Brands -1,500,000 Consumer Brand
Slide 10: Sector Performance Summary – YTD Q4 FY 2024-25
Sector Performance Summary – YTD Q4 FY 2024-25 Revenue Walk (LKR Mn) EBIT Walk (LKR Mn) 15,000 Increase Decrease Total 126,000 14,500 386 2,136 (85) 124,000 14,000 13,707 867 242 0 13,500 (652) 122,000 121,614 13,000 120,000 12,500 117,970 118,000 (4,752) 12,000 11,921 116,000 11,500 114,000 11,000
Slide 11: Continuing Operation EPS – Q4 FY 2024-25
Continuing Operation EPS – Q4 FY 2024-25 EPS Walk (LKR Per Share) 3.50 3.00 0.67 0.07 0.49 2.70 (0.01) 3.00 (0.01) (0.09) 2.50 0.59 2.70 (0.43) 2.50 2.05 2.00 2.05 2.00 1.50 1.50 1.00 1.00 0.50 0.50 - - EBIT NCI Q4 FY 25 Healthcare Consumer Brands Q4 FY 25 Q4 FY 24 Net Finance Cost Income Tax Q4 FY
Slide 12: Capital Employed – FY 2024-25
Capital Employed – FY 2024-25 Sector Efficiency Capital Employed, ROCE, and EBIT by Sector 70% Mobility LKR 1,489 Mn Consumer 60% LKR 6,918 Mn 54.2% 50% Healthcare LKR 6,521 Mn 40% 38.2% ROCE (%) 30% Group ROCE : 25.6 % 22.3% 20% 10% 0% Capital Employed (LKR Mn) - 5,000 10,000 15,000 20,000 25,000 3
Slide 13: Consumer Brands
Consumer Brands ❖ Home and Personal Care - Sri Lanka ❖ Consumer Brands- International ❖ Learning Segment
Slide 14: Consumer Brands
Consumer Brands Contribution to Group Sector Performance – 12M FY 2024-25 Revenue % 39% Revenue (LKR Mn) Key Highlights 12M FY25 42% 20.8% 12M FY24 (YoY) • Strategic price revisions taken during the previous quarters impacted 16,055 revenue while cautious volume growth EBITDA % 49% 12,741 8,865 10,9
Slide 15: Home and Personal Care – Sri Lanka
Home and Personal Care – Sri Lanka 8 Key categories with market Purpose-driven brands touching the lives of the Sri Lankan consumer leading positions Extensions & relaunches to the Portfolio Inclusive Strong roots Parenting Stronger Make a Celebrating Enabling Both parents together Positive Differen
Slide 16: Home and Personal Care – International
Home and Personal Care – International Reach in Bangladesh Locally led and localised in Bangladesh @ Operating in Bangladesh • All products are exclusively designed for Bangladesh. Rural penetration by 19.3% Hemas Key categories • Extensive product portfolio with multiple value 3• Value added and Pu
Slide 17: Home and Personal Care – Sri Lanka and International
Home and Personal Care – Sri Lanka and International Sri Lanka International Revenue Revenue Revenue (LKR Mn) • The personal wash and home care segments 12.4% • Revenue was boosted by market share growth. experienced Revenue de- growth primarily on account of strategic price reductions (YoY) • 'Kuma
Slide 18: Learning Segment
Learning Segment Revenue • In response heightened competition from 7 Key categories new entrants offering products at lower price points and varying quality, several Revenue (LKR Mn) initiatives were launched to increase awareness and create a unique and innovative point of difference, such as the H
Slide 19: Healthcare Sector
Healthcare Sector ❖ Pharmaceutical Import, Marketing and Distribution ❖ Pharmaceutical Manufacturing ❖ Hospitals
Slide 20: Healthcare
Healthcare Contribution to Group Sector Performance – 12M FY 2024-25 59% Revenue % Revenue (LKR Mn) Key Highlights 12M FY25 8.3 % 12M FY24 57% (YoY) • The Healthcare industry has been gaining momentum and recovering from the downturn experienced during the economic 19,746 18,237 17,442 16,130 16,657
Slide 21: Pharmaceutical Import, Marketing, Distribution and Manufacturing
Pharmaceutical Import, Marketing, Distribution and Pharmaceutical Manufacturing Revenue Revenue (LKR Mn) • The Distribution business continues to sustain its market-leading 7.5 % position this quarter. (YoY) • Pharmaceutical Manufacturing business of the Group continued to expand the Morison branded
Slide 22: Hospitals
Hospitals Revenue • While outpatient revenue has seen a steady Revenue (LKR Mn) increase, inpatient revenue experienced a decline 208 Beds 14.4 % due to lower admissions, which was a trend (YoY) observed across the market. +52% Hospital occupancy Profitability • GP & EBITDA margins improved owing to
Slide 23: Mobility Sector
Mobility Sector ❖Maritime ❖Aviation
Slide 24: Mobility
Mobility Contribution to Group Sector Performance – 12M FY 2024-25 2% Revenue % Revenue (LKR Mn) Key Highlights 6.3% 12M FY25 1% (YoY) 12M FY24 • Overall import volumes have increased 519 while a decline in export volumes has 487 476 477 been observed. EBITDA % 10% 458 In the aviation segment, cargo
Slide 25: Environmental Agenda 2030
ENVIRONMENTAL AGENDA 2030 2030 Goal FY 25 Milestone Facilitate the collection of 100% of Collect back 37.5% of plastic plastic sent to the sent to the market. market/consumers through initiatives across the country. 25% of Energy obtained through 10.6% of energy obtained renewable sources. through r
Slide 26: Social Impact: Focus Areas FY 25
SOCIAL IMPACT : FOCUS AREAS FY 25: 255,800+ FAMILIES EMPOWERED Creating Equal Supporting Health and Empowering Vulnerable Opportunities for Learning Well-being Communities • Empowering women • Creating quality • Providing expert advise with entrepreneurship, educational and guidance to knowledge-bui
Slide 27: Social Impact: 49,000+ Families Empowered
SOCIAL IMPACT: 49,000+ FAMILIES EMPOWERED CREATING EQUAL LEARNING TACKLING PERIOD POVERTY PROVIDING WIGS TO CANCER PATIENTS CREATING A SAFER WORLD OPPORTUNITY 58,500 1,700 17,800 101,800+ Women and Girls Women Children, Teachers and Parents Families CREATING QUALITY LEARNING EMPOWERING WOMEN AND PRO
Slide 28: Sustainability Performance – FY 24 vs FY 25
SUSTAINABILITY PERFORMANCE – FY 24 VS FY 25 Values of Fines for Non- Carbon Footprint Compliance with Laws and (per Rs. Mn Revenue) -% 0.09MT Regulations in the Social NONE Economic Area Water Consumption Total Work-Related Injury Rate (per Rs. Mn Revenue) 6.2% 1.5 m3 (per 100 employee) 11.2% 0.7 Wa
Slide 29: Key Priorities
Key Priorities Focus on Personal care, Beauty and wellness with a drive for premiumisation and exploring underpenetrated markets Corporate Priorities Strengthening value prepositions to grow market share Consumer Brands Accelerating the M&A opportunities Accelerate exports and international expansio
Slide 30: Disclaimer
Disclaimer The material in this presentation has been prepared by Hemas Holdings PLC (“Hemas”) and is general background information about Hemas’ activities current as at the date of this presentation. This information is given in summary form and does not purport to be complete. Information in this